Figure 3
Neutralizing activity of the three antibodies.
(A) Neutralization of of VSVΔG-EBOVGP-eGFP by fluorescent plaque counting. (B) Neutralization of EBOV/May-eGFP by fluorescent plaque counting. The results are expressed as normalized plaque count, where 100% was set to incubation of cells with virus only, i.e. in absence of mAbs.
